Concepedia

Kimihisa Ichikawa

KI

21

Publications

1.3K

Citations

16

H-Index

1979

Active since

Affiliations

Daiichi-Sankyo (Japan)(Current)

Biomedical Research Laboratories (United States)

National Institute of Advanced Industrial Science and Technology

University of Tsukuba

Shin Nippon Biomedical Laboratories (Japan)

Kimihisa Ichikawa is an author at Daiichi-Sankyo (Japan) specializing in medicine, immunology, and immunotherapy.

Top concepts

Publications per year

1979–2018

21

Publications

21

Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity

Kimihisa Ichikawa, Weimin Liu, Limin Zhao et al. · Nature Medicine · 2001 · 543 citations

, , +10

TRAIL-R2 (DR5) Mediates Apoptosis of Synovial Fibroblasts in Rheumatoid Arthritis

Kimihisa Ichikawa, Weimin Liu, Martin Fleck et al. · The Journal of Immunology · 2003 · 119 citations

A novel humanized anti-human death receptor 5 antibody CS-1008 induces apoptosis in tumor cells without toxicity in hepatocytes

A. Yada, Michio Yazawa, Shuji Ishida et al. · Annals of Oncology · 2008 · 93 citations

, , +10

Identification of 2′-Phosphodiesterase, Which Plays a Role in the 2-5A System Regulated by Interferon

Kazuishi Kubota, Kaori Nakahara, Toshiaki Ohtsuka et al. · Journal of Biological Chemistry · 2004 · 78 citations · Full text

A novel murine anti-human Fas mAb which mitigates lymphadenopathy without hepatotoxicity

Kimihisa Ichikawa, Hiroko Yoshida-Kato, Masahiko Ohtsuki et al. · International Immunology · 2000 · 54 citations

, , +21

Rows per page

1–5 of 21